Published: May 2021 | Report Code: LS12181 | Available Format: PDF | Pages: 222
The topical scar treatment market in China, South Korea, Taiwan, Hong Kong, and Southeast Asia generated $701.6 million revenue in 2020, and it is expected to grow at a CAGR of 7.7% during the forecast period (2021–2030). The key factors responsible for the growth of the market include the rising incidence of burns, increasing number of road accidents, surging cases of skin diseases, growing aging population, and escalating disposable income.
During the COVID-19 pandemic, the demand for topical scar treatment products reduced due to movement restrictions, which forced people to stay home, and the lockdowns. Moreover, companies faced disruptions in the supply chain during the first wave in 2020, which are again being observed in 2021. Thus, there has been a strong negative impact of the pandemic on the sale of topical scar treatment products.
The cream category held the largest share in 2020 in the topical scar treatment market of China, South Korea, Taiwan, Hong Kong, and the SEA region, based on product type. This is majorly attributed to the fact that creams fade, smoothen, flatten, and reduce both old and new scars and prevent the formation of new scars.
The atrophic and acne scar category dominated the topical scar treatment market in 2020, and it is expected to be the fastest-growing category during the forecast period, based on scar type. This will majorly be due to the high prevalence of atrophic and acne scars among adolescents owing to hormonal changes and their unhealthy eating habits. Over 90% of the teenagers have acne, which results in a high demand for topical products.
The pharmacies category accounted for the largest share in the market for topical scar treatment in 2020, and it is expected to retain its position during the forecast period, based on distribution channel. This is majorly due to the fact that patients with scars prefer to purchase these products from pharmacies. Moreover, most of the products require a prescription from a dermatologist.
Geographically, China was the largest contributor to the market for topical scar treatment in 2020, and it will also witness the fastest growth in the coming years. This is mainly attributed to the increasing geriatric population and rapid economic development, which are enhancing the demand for technologically advanced scar treatment products in the country. Moreover, the growing disposable income of the people in China and rising prevalence of skin diseases are further boosting the market advance.
Silicone-based scar treatment solutions are attracting the attention of the populace. Silicone gel sheets manufactured from a synthetic silicone gel-like material are used to fill surgical scars and treat superficial scars, hypertrophic scars, and keloids. Silicone gel increases the hydration of the stratum corneum and, thus, facilitates fibroblast production and collagen reduction and protects the scar from bacterial invasion. Some of the silicone-based scar treatment products are bioCorneum by Sientra Inc., Dermatix by Mylan N.V., and ScarAway by Perrigo Company plc.
During the healing of burns, scars often form after skin damage, appearing as thick and discolored skin. According to an article published in the Experimental and Therapeutic Science journal in April 2019, more than 10 million individuals suffer from burns every year in China. Moreover, according to an article published in the journal Annals of Burns and Fire Disasters, in 2019, the elderly burn incidence in Vietnam was 4.2%, with over half the patients suffering from deep burn injuries. The increasing incidence of burns is resulting in the rising demand for topical scar treatment products in SEA countries.
|Base Year (2020) Market Size||$701.6 Million|
|Market Size Forecast in 2030||$1,451.1 Million|
|Forecast Period (2021-2030) CAGR||7.7%|
|Report Coverage||Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Country Breakdown; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis; Company Profiling|
|Market Size by Segments||By Product Type; By Scar Type; By Distribution Channel; By Country|
|Market Size of Geographies||China; Indonesia; Philippines; Vietnam; Thailand; South Korea; Malaysia; Taiwan; Hong Kong|
|Secondary Sources and References (Partial List)||American Academy of Dermatology; Asian Dermatological Association; Asian Academy of Dermatology and Venereology; Asian Society of Dermatopathology; American Burn Association; British Association of Aesthetic Plastic Surgeons; British Association of Dermatologists; Canadian Association of Orthodontists; European Academy of Dermatology and Venereology; European Spas Association; French Society of Dermatology; International Society of Aesthetic Plastic Surgery; International Academy of Cosmetic Dermatology; Italian Society of Dermatology; United States Food and Drug Administration; U.S. National Library of Medicine; World Health Organization|
The market in China, South Korea, Taiwan, Hong Kong, and SEA is fragmented in nature. Some of key players in topical scar treatment market in China, South Korea, Taiwan, Hong Kong, and Southeast Asia are Perrigo Company plc, Laboratoire HRA Pharma SAS, Terez & Honor, Sientra Inc. , Aroamas LLC, Integra LifeSciences Holdings Corporation, Revitol Corporation, Sonoma Pharmaceuticals Inc., Smith & Nephew PLC, Mölnlycke Health Care AB, Mylan N.V., Merz Pharma GmbH & Co. KGaA, Alliance Pharma plc, and Johnson & Johnson .
In recent years, players in the topical scar treatment industry have been involved in product launches in order to attain a significant position. For instance:
The topical scar treatment market report offers comprehensive market segmentation analysis along with market estimation for the period 2015–2030.
Based on Product Type
Based on Scar Type
Based on Distribution Channel
During 201–2030, the market for topical scar treatment products in China, South Korea, Taiwan, Hong Kong, and Southeast Asia (SEA) will witness a CAGR of 7.7%.
Creams are preferred by the end users, as they not only treat existing scars but also prevent new scars from forming.
China is the largest country in the market for topical scar treatment products in China, South Korea, Taiwan, Hong Kong, and Southeast Asia (SEA).
The China, South Korea, Taiwan, Hong Kong, and Southeast Asia (SEA) topical scar treatment industry is being driven by the rising incidence of burns, road accidents, and dermatological diseases.
The market for topical scar treatment products in China, South Korea, Taiwan, Hong Kong, and Southeast Asia (SEA) is fragmented.
Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws